ROCO
6518
Market cap28mUSD
Nov 12, Last price
26.30TWD
Name
Concord Medical Co Ltd
Chart & Performance
P/E
17.69
P/S
0.99
EPS
1.49
Div Yield, %
3.80%
Shrs. gr., 5y
5.93%
Rev. gr., 5y
3.10%
Revenues
890m
+6.80%
Net income
50m
+15.97%
CFO
149m
+31.45%
Dividend
Apr 02, 20241 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Concord Medical Co., Ltd. provides hospital management support services in Taiwan, Myanmar, and China. It offers medical management services that include medical training and nursing staffing, and assisting on medical management; and procurement services for equipment, drugs, medical materials and consumables, inspection equipment, and reagents and consumables, as well as develops its own brand for medical beauty care products, health foods, and finished Chinese medicine products. The company is also involved in the medical equipment planning and sales; and medical equipment leasing activities. Concord Medical Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||